(Press-News.org) A single daily preventer dose of inhaled corticosteroid (beclomethasone), taken mid afternoon, may be the best timing for effective asthma control as it suppresses the usual nocturnal worsening of symptoms more effectively than dosing regimens at other times of the day, suggest the results of a small clinical trial published in the journal Thorax.
If the findings are confirmed in larger studies, this approach may lead to better clinical outcomes for patients without increasing unwanted steroidal side effects or medical costs, suggest the researchers.
Aligning the timing of drug treatment with the body clock, known as chronotherapy, can enhance the therapeutic effects of medicines, say the researchers.
This may be particularly important in asthma, which has a distinct daily rhythm, with the cardinal effects of airflow obstruction and airway inflammation peaking overnight, when 80% of fatal asthma attacks occur, they explain.
Drawing on their previously published research, showing enhanced immune cell responsiveness to steroids mid afternoon, the researchers wanted to find out if a single dose of preventer inhaler at this time would better suppress the usual nocturnal worsening of asthma symptoms than either morning or standard twice-daily dosing, and without increasing the risk of steroidal side effects.
Twenty five people (aged 18-65) with confirmed mild to moderate asthma lasting at least a year, and common respiratory allergies to cat hair, dust mites, or grass pollen, were randomly assigned to one of three dosing regimens for 28 days each.
These comprised a single daily dose of 400 µg beclomethasone between 0800 and 0900 hours; the same once daily dose between 1500 and 1600 hours; and a twice daily dose of 200 µg beclomethasone between 0800 and 0900 hours and between 20.00 and 21.00 hours.
At the end of each 28 day period, participants swapped their dosing regimen after a 14 to 21 day gap until all three trial arms had been completed.
Spirometry readings and blood biomarkers (inflammatory cells, levels of cortisol and salbutamol from reliever inhalers) were measured every 6 hours for 24 hours at the start and end of each of the 28 day periods.
Twenty one people (84%), all of whom had similar sleep-wake cycles, completed all three of the trial arms.
Compared with baseline measurements, all the treatment arms improved night time lung function. But the timing of the improvement differed according to the dosing regimen. The largest Improvement, measured at 22:00 hours, was associated with the once daily mid afternoon dose (100 ml more than the morning dose).
Similarly, all the dosing regimens suppressed airway inflammation compared with baseline levels. And this was significantly lower at 22.00 and 0400 hours with the once daily mid afternoon dose than it was with the twice daily dose.
There was no difference in cortisol levels between the three dosing regimens, compared with baseline levels, suggesting that there was no additional impairment in the body’s ability to produce the hormone—a potential side effect of inhaled steroid treatment.
The researchers acknowledge the small number of participants involved and the short length of their study, but suggest that the findings might form the basis of further larger trials.
“Our findings further support the hypothesis that the optimal timing of [inhaled corticosteroid] administration is at 16:00, coincident with enhanced glucocorticoid sensitivity at that time,” they say.
“The notion that the onset of the inflammatory cascade begins mid-afternoon may also explain the findings we observed, and the attenuation of the predictable rhythmic recruitment of airway inflammatory cells at this time point may abolish the subsequent excessive nocturnal dip in lung function in asthma,” they suggest.
In a linked editorial, Drs Richard Russell and Nicola Smallcombe of, respectively, the King’s Centre for Lung Health, King’s College London,and the Royal Free London NHS Foundation Trust, point out that the mid afternoon dosing regimen did not result in better symptom control.
But they explain: “This lack of translation to patient outcomes may be attributed to the short duration of the follow-up period, the small numbers, and the relatively low symptom burden of participants at baseline, so there was no headroom for improvement.”
Because participants had mild to moderate asthma, and long acting beta agonist inhalers—recommended in the latest treatment guidelines—weren’t included, the results might not be applicable more widely, they suggest.
“Additionally, when one considers the translation of these findings into clinical practice, with adherence to asthma therapies being the greatest challenge – around 30–40% of the general population struggles with inhaler compliance – introducing a specific time for inhaler use could potentially complicate matters further,” they surmise.
But they conclude: “This study offers promising insights into the potential benefits of using chronotherapy with inhaled corticosteroids for asthma patients. We believe that this is most likely to benefit those with more severe asthma, where marginal gains in lung function and a reduced eosinophil count are more likely to translate into better control and risk reduction.”
END
Single mid-afternoon preventer inhaler dose may be best timing for asthma control
Better suppresses usual nocturnal worsening of asthma than dosing at other times. May lead to better outcomes without increasing steroid-related side effects or costs
2025-04-15
ELSE PRESS RELEASES FROM THIS DATE:
Symptoms of ice cold feet + heaviness in legs strongly linked to varicose veins
2025-04-15
Hypersensitivity to the cold, especially ice cold feet, as well as a feeling of heaviness in the legs, are linked to the presence of varicose veins, finds a large study published in the open access journal Open Heart.
Cold hypersensitivity is often underestimated as a subjective symptom, say the researchers.
Varicose veins are usually caused by impaired functioning of the deep or superficial veins, and the perforator veins (short veins that link the superficial and deep venous systems in the legs).
The prevalence of varicose veins ranges from 2% to 30% in adults, with women at higher risk. And symptoms include sensations ...
Brain areas necessary for reasoning identified
2025-04-15
A team of researchers at UCL and UCLH have identified the key brain regions that are essential for logical thinking and problem solving.
The findings, published in Brain, help to increase our understanding of how the human brain supports our ability to comprehend, draw conclusions, and deal with new and novel problems – otherwise known as reasoning skills.
To determine which brain areas are necessary for a certain ability, researchers study patients with brain lesions (an area of damage in the brain) caused by stroke or brain tumours. This approach, known ...
Growing wildflowers on disused urban land can damage bee health
2025-04-15
Wildflowers growing on land previously used for buildings and factories can accumulate lead, arsenic and other metal contaminants from the soil, which are consumed by pollinators as they feed, a new study has found.
The metals have previously been shown to damage the health of pollinators, which ingest them in nectar as they feed, leading to reduced population sizes and death. Even low nectar metal levels can have long-term effects, by affecting bees’ learning and memory - which impacts their foraging ability.
Researchers have found that common plants including white clover and bindweed, which ...
Rapid rise in vaping in Britain has stalled
2025-04-15
The study, published in the journal Addiction and funded by Cancer Research UK, looked at survey data on vaping habits in England, Wales and Scotland before and after the UK Government announced plans to restrict vaping, including by banning disposable vapes, in January 2024.
The team found that the proportion of people vaping increased by nearly a quarter each year from January 2022 to January 2024, but stayed constant between January 2024 and January this year, including for young people.
After January 2024, they also found a substantial decline in the proportion of vapers mainly using disposable e-cigarettes. Among 16- to 24-year-olds, the proportion ...
Young minds, big ideas: Florida’s first Invention Convention ignites innovation at USF
2025-04-15
TAMPA, Fla. (April 15, 2025) – The University of South Florida recently hosted the inaugural Invention Convention Florida at the University of South Florida, an event noted for showcasing the creativity and problem-solving of the next generation of changemakers. Moere than 150 K–12 student inventors from across the state visited USF’s Tampa campus on April 12 to present original solutions to real-world challenges ranging environmental issues to everyday inconveniences.
Invention Convention Florida, ...
New study reveals how to make prescribed forest fires burn safer and cleaner
2025-04-15
Prescribed burns literally fight fire with more fire. Often referred to as a “beneficial fire,” they target areas at risk for wildfires and burn away material that could otherwise fuel a future blaze.
However, all fires, whether accidental or planned, produce smoke that can cause health and respiratory issues, especially in nearby communities. Burning fires release harmful chemicals, like polycyclic aromatic hydrocarbons (PAHs), that are carcinogenic – PAHs can cause cancer, lung damage, and lead to weakened immunity in those who inhale smoke.
Recently, in a study published in Atmospheric ...
Inactive components in agricultural runoff may be hidden contributors to drinking water hazards
2025-04-15
Inactive ingredients in agricultural, pharmaceutical and other common products have typically been excluded from consideration as potential contaminants in drinking water. However, while these chemicals are inert in certain products, they still can pose hazards when combined with other materials during the drinking water treatment process.
A new study from researchers in the McKelvey School of Engineering at Washington University in St. Louis reveals how large this impact might be. Jean Brownell, a graduate student working with Kimberly Parker, associate professor of energy, environmental & chemical engineering, ...
Colombia’s peatlands could be a crucial tool to fight climate change. But first we have to find them
2025-04-15
UC Santa Cruz Assistant Professor of Environmental Studies Scott Winton has been wading through thick, smelly muck in the tropics for almost a decade. He wouldn’t have it any other way. As a wetland ecologist and biogeochemist, he’s been hard at work investigating an important and mysterious topic: peatlands.
Peatlands are a special type of wetland with enormous potential to either help or hurt global efforts to address climate change. If we want peatlands on our side, we’ll have to protect them. But that’s difficult to do, since we still don’t ...
Researchers refine a hybrid music therapy intervention for patients with cardiac and pulmonary conditions
2025-04-15
CLEVELAND – A new study from University Hospitals Connor Whole Health found that it was feasible to conduct a hybrid music therapy intervention for patients with heart failure and patients with chronic obstructive pulmonary disease (COPD). Participants reported positive effects on their mental health, and the pilot uncovered solutions to improve future research with this population. The findings from this study were recently published in BMC Complementary Medicine and Therapies.
Patients with chronic illnesses such as heart failure and COPD face significant challenges due ...
Research Spotlight: Combining dexmedetomidine with spinal anesthesia prolongs pain relief and decreases shivering during surgery
2025-04-15
Heitor Medeiros, MD, and A. Sassan Sabouri, MD, of the Department of Anesthesia, Critical Care and Pain Medicine at Massachusetts General Hospital, are the lead and corresponding authors, respectively, of a paper published in the British Journal of Anaesthesia (BJA).
How would you summarize your study?
Spinal anesthesia is widely used to numb patients during surgery, but its effects sometimes wear off too soon. Many anesthetists have experimented with adding extra drugs to extend pain relief. Dexmedetomidine demonstrated results in multiple randomized clinical trials suggesting it could prolong numbness ...
LAST 30 PRESS RELEASES:
Father’s mental health can impact children for years
Scientists can tell healthy and cancerous cells apart by how they move
Male athletes need higher BMI to define overweight or obesity
How thoughts influence what the eyes see
Unlocking the genetic basis of adaptive evolution: study reveals complex chromosomal rearrangements in a stick insect
Research Spotlight: Using artificial intelligence to reveal the neural dynamics of human conversation
Could opioid laws help curb domestic violence? New USF research says yes
NPS Applied Math Professor Wei Kang named 2025 SIAM Fellow
Scientists identify agent of transformation in protein blobs that morph from liquid to solid
Throwing a ‘spanner in the works’ of our cells’ machinery could help fight cancer, fatty liver disease… and hair loss
Research identifies key enzyme target to fight deadly brain cancers
New study unveils volcanic history and clues to ancient life on Mars
Monell Center study identifies GLP-1 therapies as a possible treatment for rare genetic disorder Bardet-Biedl syndrome
Scientists probe the mystery of Titan’s missing deltas
Q&A: What makes an ‘accidental dictator’ in the workplace?
Lehigh University water scientist Arup K. SenGupta honored with ASCE Freese Award and Lecture
Study highlights gaps in firearm suicide prevention among women
People with medical debt five times more likely to not receive mental health care treatment
Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B
Rise in claim denial rates for cancer-related advanced genetic testing
Legalizing youth-friendly cannabis edibles and extracts and adolescent cannabis use
Medical debt and forgone mental health care due to cost among adults
Colder temperatures increase gastroenteritis risk in Rohingya refugee camps
Acyclovir-induced nephrotoxicity: Protective potential of N-acetylcysteine
Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury
AERA announces winners of the 2025 Palmer O. Johnson Memorial Award
Mapping minds: The neural fingerprint of team flow dynamics
Patients support AI as radiologist backup in screening mammography
AACR: MD Anderson’s John Weinstein elected Fellow of the AACR Academy
Existing drug has potential for immune paralysis
[Press-News.org] Single mid-afternoon preventer inhaler dose may be best timing for asthma controlBetter suppresses usual nocturnal worsening of asthma than dosing at other times. May lead to better outcomes without increasing steroid-related side effects or costs